ANRO Alto Neuroscience, Inc. logo

ANRO Alto Neuroscience, Inc.

Healthcare
$21.22-1.49%ClosedMarket Cap: $744.7M

As of 2026-05-25

Insider Statistics (Q2 2026)

Acquisitions

5

Dispositions

1

Buy/Sell Ratio

5.00

Net Shares

-345,210

Shares Acquired

54,790

Shares Disposed

400,000

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri May 15Etkin Amitdirector, officer: PRESIDENT AND CEOSell400,000$0.00833,949
Thu May 14York GwilldirectorSell10,958$24.6310,958
Thu May 14Sanchez RamirodirectorSell10,958$24.6310,958
Thu May 14Manji HusseinidirectorSell10,958$24.6310,958
Thu May 14Dreyfus AndrewdirectorSell10,958$24.6310,958
Thu May 14Cox Christopher NixondirectorSell10,958$24.6310,958
Tue Mar 03Smith Nicholas Conradofficer: CHIEF FINANCIAL OFFICER & CBOSell2,806$19.6924,060
Tue Mar 03Etkin Amitdirector, officer: PRESIDENT AND CEOSell6,227$19.691,233,949
Fri Feb 13Smith Nicholas Conradofficer: CHIEF FINANCIAL OFFICER & CBOSell200,000$16.71200,000
Fri Feb 13Savitz Adamofficer: CHIEF MEDICAL OFFICERSell124,000$16.71124,000
Fri Feb 13Hanley Jr. Michael Conickofficer: CHIEF OPERATING OFFICERSell131,000$16.71131,000
Fri Feb 13Etkin Amitdirector, officer: PRESIDENT AND CEOSell306,000$16.71306,000
Tue Jan 06York GwilldirectorSell5,243$16.595,243
Tue Jan 06Sanchez RamirodirectorSell3,806$16.593,806
Tue Jan 06Manji HusseinidirectorSell4,228$16.594,228